**Role Summary**

The Clinical and Translational Biomarker (CTB) Lead will be responsible for developing translational biomarker strategies for assigned assets with a focus on inflammatory and autoimmune disease within the Pfizer Research & Development portfolio from Lead Development through FIH, through Phase 2 and 3 including registration and post-marketing activities. The lead is also accountable and responsible for implementation of this strategy through scientific and technical leadership, oversight and management of external and internal partners involved in delivering quality, timely, and regulatory compliant biomarker analytical assays and data. They contribute to biomarker sections of the clinical development plans, clinical protocols, internally- and externally-facing presentations and manuscripts, regulatory filings, label claims and registration paths.

**Role Responsabilities**

+ Utilize understanding of disease biology and therapeutic mechanism o...